GIP infusion, which was started at 10.8 pmol/kg/min and gradually decreased to 4.0 pmol/kg/min at 240 min, reduced the mean arterial blood pressure by 10–15 mmHg, and increased the heart rate by < 8 bpm in individuals with normal glucose tolerance, impaired glucose tolerance, or type 2 diabetes (n = 10 [men, 6; women, 4], 10 [men, 6; women, 4], and 9 [men, 3; women, 6], respectively; no information for ethnicity) [114]. Here, GIP is linked to type 2 diabetes mellitus.